It’s great to see The Nation – a venerable journal of progressive opinion and analysis – expanding its coverage of human biotechnologies. In the past few years, Patricia J. Williams’ regular column “Diary of a Mad Law Professor” has taken on topics including precision medicine, “genetic race,” and surrogacy. Now, historian Nathaniel Comfort’s epic article, “Can We Cure Genetic Diseases Without Slipping Into Eugenics?,” looks at the new DNA editing tool CRISPR in the context of the United States’ eugenics movement.
Nathaniel Comfort, author of The Science of Human Perfection, writes about enthusiasts who advocate using new genetic engineering techniques to attempt to alter the traits passed on to future generations, a practice called human germline modification. Some public personae embrace the term “liberal eugenics” and argue that a “free-market environment with real individual choice” is the best way to protect us from repeating past eugenic abuses. But, as Comfort warns, “liberal eugenics is really neoliberal eugenics.” And the invisible hand of the market isn’t pulling back on the reigns of technological progress anytime soon.
In countries outside the U.S. with a more honest memory of state-controlled human betterment projects, there is no beating around the bush of what’s at stake. In addition to the history of public outcry that Comfort recounts, there has been an international consensus for decades that engineering the human germline is off-limits. More than 40 nations have passed legislation to ban it outright—including nearly all nations with developed biotech sectors except for the United States.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.